‡ In these countries please contact our distributor

2015 third quarter trading report

We announced our third quarter trading report for the period ended 26 September 2015 on Thursday 29 October 2015.

We deliver 4% underlying revenue growth; maintain full year guidance

Read the press release here
Adobe Acrobat PDF icon Download a PDF of the full announcement here (PDF 100KB)

Listen to the audio webcast here.

Adobe Acrobat PDF icon View the presentation slides here (PDF 750KB)

Adobe Acrobat PDF icon View the Transcript here (PDF 207KB)



Investors/ Analysts
Ingeborg Øie +44 (0) 20 7960 2285
Smith & Nephew plc

Charles Reynolds +44 (0) 20 7401 7646
Smith & Nephew plc

Ben Atwell / Deborah Scott / Matthew Cole +44 (0) 20 3727 1000
FTI Communications


Forward-looking Statements

This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith & Nephew, these factors include: economic and financial conditions in the markets we serve, especially those affecting health care providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; strategic actions, including acquisitions and dispositions, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20-F, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith & Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith & Nephew are qualified by this caution. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith & Nephew's expectations.

Capital Markets event

10 November, 2015
London, UK

Smith & Nephwe Hull factory at night

Hosted by Olivier Bohuon, Chief Executive Officer. Insights into our Advanced Wound Management franchises for institutional investors and analysts.